ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles-Reference-Cited by-同舟云学术

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

Published:2006-07-09 Issue:8 Volume:38 Page:873-875
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Renwick Anthony, ,Thompson Deborah,Seal Sheila,Kelly Patrick,Chagtai Tasnim,Ahmed Munaza,North Bernard,Jayatilake Hiran,Barfoot Rita,Spanova Katarina,McGuffog Lesley,Evans D Gareth,Eccles Diana,Easton Douglas F,Stratton Michael R,Rahman Nazneen

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1837.pdf

Reference13 articles.

1. Shiloh, Y. Nat. Rev. Cancer 3, 155–168 (2003).

2. Swift, M. et al. N. Engl. J. Med. 316, 1289–1294 (1987).

3. Thompson, D. et al. J. Natl. Cancer Inst. 97, 813–822 (2005).

4. Fitzgerald, M.G. et al. Nat. Genet. 15, 307–310 (1997).

5. Teraoka, S.N. et al. Cancer 92, 479–487 (2001).

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing;Annals of Oncology;2024-10

2. Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with hereditary gastric cancer linked to a family history of hereditary breast and ovarian cancer (HBOC);2024-09-05

3. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2;Critical Reviews in Oncology/Hematology;2024-09

4. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer;Journal of Experimental & Clinical Cancer Research;2024-08-21

5. Germline BRCA1‐Mutated Synchronous and Metachronous Pancreatic Acinar Cell Carcinoma With Long‐Term Survival;Cancer Reports;2024-08